Patent · US Active

(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

US10064868B2 · kind B2 · utility

7Cited by

9References

15Claims

0Family size

Assignee

MEI PHARMA, INC. · US

Inventors

S. David Brown · Redwood City, US
David Matthews · Lindon, US

Key dates

Filing date	Jun 3, 2015
Grant date	Sep 4, 2018
Priority date	—
Expiry date	Jun 3, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N9/1205
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are (alpha-substituted aralkylamino or heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, e.g., a compound of Formula I, and their pharmaceutical compositions, preparation, and use as agents or drugs for treating proliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.